Effect of Patient Navigator Program on No-Show Rates at an Academic Referral Colposcopy Clinic

Journal of Women's Health

Volumn 24, Issue 7, 2015, Pages 608-615

  Luckett, Rebecca ^a   Pena, Nancy ^b   Vitonis, Allison ^a   Bernstein, Marilyn R ^b   Feldman, Sarah ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; COLPOSCOPY; COMORBIDITY; CYTOLOGY; DEMOGRAPHY; FEMALE; FEMALE FERTILITY; HEALTH INSURANCE; HISPANIC; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PATIENT NAVIGATOR PROGRAM; PATIENT REFERRAL; PREGNANCY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SMOKING; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; UTERINE CERVIX DYSPLASIA; ATTITUDE TO HEALTH; BLACK PERSON; EARLY DIAGNOSIS; ETHNOLOGY; HOSPITAL MANAGEMENT; MIDDLE AGED; PROGRAM EVALUATION; PSYCHOLOGY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL; UTERINE CERVICAL NEOPLASMS; UTILIZATION;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; APPOINTMENTS AND SCHEDULES; COLPOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HOSPITALS, TEACHING; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT NAVIGATION; PROGRAM EVALUATION; REFERRAL AND CONSULTATION; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84937035452     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2014.5111     Document Type: Article

References (33)

1. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER stat fact sheets: Cervix uteri cancer. Available at: http://seer. cancer. gov/statfacts/html/ cervix. html Accessed on Aug. 7, 2013.
2. Natale-Pereira A, Enard K, Nevarez L, Jones LA. The role of patient navigators in eliminating health disparities. Cancer 2011;117(15 suppl):3543-3552.
3. Beach MC, Gary TL, Price EG, et al. Improving health care quality for racial/ethnic minorities: A systematic review of the best evidence regarding providers and organization interventions. BMC Public Health 2006;24:104.
4. Glick S, Clarke A, Blanchard A, Whitaker AK. Cervical cancer screening, diagnosis and treatment interventions for racial and ethnic minorities: A systematic review. J Gen Intern Med 2012;27:1016-1032.
5. Rattanalappaiboon D, Kietpeerakool C, Kleebkaow P, et al. Factors affecting compliance in the first year of postcolposcopy surveillance among women with a high incidence of cervical cancer. Int J Gynaecol Obstet 2014;124: 160-163.
6. Chase DM, Osann K, Sepina N, Wenzel L, Tewari KS. The challenge of follow-up in a low-income colposcopy clinic: Characteristics associated with noncompliance in high-risk populations. J Low Genit Tract Dis 2012;16:345-351.
7. Paskett ED, White E, Carter WB, Chu J. Improving followup after an abnormal pap smear: A randomized controlled trial. Prev Med 1990;19:630-641.
8. Khanna N, Phillips, M. Adherence to care plan in women with abnormal Papanicolau smears: A review of barriers and interventions. J Am Board Fam Pract 2001;14:123-130.
9. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 1995;3:19-30.
10. Battaglia T, Burhansstipanov L, Murrell S, et al. Assessing the impact of patient navigation: Prevention and early detection metrics. Cancer 2011;117(15 suppl):3553-3564.
11. Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: Methods, protocol, and measures. Cancer 2008;113:3391-3399.
12. Battaglia T, Bak S, Heeren T, et al. Boston Patient Navigation Research Program: The impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev 2012;21: 1645-1654.
13. Freeman H, Rodriguez R. History and principles of patient navigation. Cancer 2011;117(15 suppl):3539-3543.
14. "What are patient navigators?" Center to Reduce Cancer Health Disparities: Patient Navigator Programs. U. S. National Institutes of Health. Available at: http://crchd. cancer. gov/pnp/what-are. html Accessed on August 9, 2014.
15. Tejeda S, Darnell J, Cho Y, Stolley MR, Markossian TW, Calhoun EA. Patient barriers to follow-up care for breast and cervical cancer abnormalities. J Womens Health (Larchmt) 2013;22:507-517.
16. Percac-Lima S, Ashburner J, Bond B, Oo SA, Atlas SJ. Decreasing disparities in breast cancer screening in refugee women using culturally tailored patient navigation. J Gen Intern Med 2013;28:1463-1468.
17. Percac-Lima S, Benner C, Lui R, et al. The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women. J Womens Health (Larchmt) 2013;22:426-431.
18. Fernandez ME, Gonzales A, Tortolero-Luna G, et al. Effectiveness of Cultivando la Salud: A breast and cervical cancer screening promotion program for lowincome Hispanic women. Am J Public Health 2009;99: 936-943.
19. Jeudin P, del Carmen M, Battaglia T, et al. Effect of patient navigation on adherence to follow-up after treatment of high-grade dysplasia. Obstet Gynecol 2014;123: 29S (Abstract).
20. Dietrich AJ, Tobin JN, Cassells A, et al. Telephone care management to improve cancer screening among lowincome women: A randomized, controlled trial. Ann Intern Med 2006;144:563-571.
21. Ell K, Vourlekis B, Muderspach L, et al. Abnormal cervical screen follow-up among low-income Latinas: Project SAFe. J Womens Health Gend Based Med 2002;11:639-651.
22. Charlton B, Carwile J, Michels K, et al. A cervical abnormalities risk prediction model: Can we use clinical information to predict which patients with ASCUS/LSIL Pap tests will develop CIN2/3 or AIS? J Low Genit Tract Dis 2013;17: 242-247.
23. Lerman C, Hanjani P, Caputo C, et al. Telephone counseling improves adherence to colposcopy among lowerincome minority women. J Clin Oncol 1992;10:330-333.
24. del Carmen M, Avila-Wallace M. Effect of health care disparities on screening. Clin Obstet Gynecol 2013;56: 65-75.
25. Wang X, Fang C, Tan Y, Liu A, Ma GX. Evidence-based intervention to reduce access barriers to cervical cancer screening among underserved Chinese American women. J Womens Health (Larchmt) 2010;19:463-469.
26. Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW. Enhancing adherence following abnormal Pap smears among low-income minority women: A preventive telephone counseling strategy. J Natl Cancer Inst 1997;89:703-708.
27. Stewart DE, Buchegger PM, Lickrish GM, Sierra S. The effect of educational brochures on follow-up compliance in women with abnormal Papanicolou smears. Obstet Gynecol 1994;83:583-585.
28. Fernandez M, Le Y, Fernandez-Espada N, et al. Knowledge, attitudes and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: A qualitative study. Prev Chronic Dis 2014;11:E212.
29. Perez FD, Xie J, Sin A, et al. Characteristics and direct costs of academic pediatric subspecialty outpatient no-show events. J Healthc Qual 2014;36:32-42.
30. Berg BP, Murr M, Chermak D, et al. Estimating the cost of no-shows and evaluating the effects of mitigation strategies. Med Decis Making 2013;33:976-985.
31. Nuti LA, Lawley M, Turkcan A, et al. No-show to primary care appointments: Subsequent acute care utilization among diabetic patients. BMC Health Serv Res 2012;12:304.
32. Whitley E, Valverde P, Wells K, Williams L, Teschner T, Shih YC. Establishing common cost measures to evaluate the economic value of patient navigation programs. Cancer 2011;117(15 Suppl):3618-3625.
33. Moore CG, Wilson-Witherspoon P, Probst JC. Time and money: Effects of no-shows at a family practice residency clinic. Fam Med 2001;33:522-527.